Format

Send to

Choose Destination
J Invest Dermatol. 2015 Sep;135(9):2319-2321. doi: 10.1038/jid.2015.158. Epub 2015 Apr 23.

Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa.

Author information

1
St John's Institute of Dermatology, King's College London (Guy's Campus), London, UK. Electronic address: john.mcgrath@kcl.ac.uk.
2
St John's Institute of Dermatology, King's College London (Guy's Campus), London, UK.
3
St John's Institute of Dermatology, King's College London (Guy's Campus), London, UK; Department of Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
4
Cell Therapy Facility, Department of Clinical Pharmacology, University Medical Centre Utrecht, Utrecht, The Netherlands.
5
Department of Pediatrics, Blood and Marrow Transplantation Program, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
6
Department of Pediatrics, Blood and Marrow Transplant, Medical School, University of Minnesota, Minneapolis, Minnesota, USA; Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, USA.
7
Blood and Marrow Transplantation Department, Great Ormond Street Hospital, London, UK.
8
Division of Health and Social Care Research, King's College London, London, UK.
9
Department of Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
PMID:
25905587
PMCID:
PMC5696540
DOI:
10.1038/jid.2015.158
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center